1-3 of 3
Jose Luis Piñana
Close
Sort by
Journal Articles

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Pere Barba, Jose Luis Piñana, Alex Amoros, David Valcárcel, Rodrigo Martino, Anna Sureda, Javier Briones, Julio Delgado, Miquel Granell, Salut Brunet, Ma. Rosa Suñol, J. Sierra, MD
Journal: Blood
Blood (2008) 112 (11): 3277.
https://doi.org/10.1182/blood.V112.11.3277.3277
Published: 2008
Journal Articles

Cyclosporine a and Mycophenolate Mofetil Vs Cyclosporine a and Methotrexate as Gvhd Prophylaxis in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donor.

Jose Luis Piñana, Sr., David Valcarcel, MD, Rodrigo Martino, Francesc Fernandez, Pere Barba, Montserrat Rovira, MD, PhD, Enric Carreras, MD, PhD, Anna Sureda, Jorge Sierra, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2229.
https://doi.org/10.1182/blood.V112.11.2229.2229
Published: 2008
Journal Articles

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML): Report of 11 Cases.

Juan-Manuel Sancho, MD, Anne Parker, MD, Guillermo Deben, MD, Simon Bolam, MD, Eugenio Gimenez, MD, Eva Sanchez-Garcia, MD, Jose-Luis Piñana, MD, Teresa Pascual, MD, Carmen Mateos, MD, Pascual Fernandez-Abellan, MD, Luis Palomera, MD, Josep-Maria Ribera, PhD
Journal: Blood
Blood (2006) 108 (11): 4545.
https://doi.org/10.1182/blood.V108.11.4545.4545
Published: 2006